Author

S. K. Best

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. V. R. Lake· 1 shared B. Basu· 1 shared C. A. Johnson· 1 shared C. E. L. Smith· 1 shared J. Bond· 1 shared R. Foster· 1 shared R. Trowbridge· 1 shared S. N. Grellscheid· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. V. R. Lake

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathies.

A. V. R. Lake, C. E. L. Smith, S. Natarajan, B. Basu, S. K. Best, T. Stevenson, R. Trowbridge, S. N. Grellscheid, J. Bond, R. Foster, C. A. Johnson

The paper identifies ROCK2 as a therapeutic target for ciliopathies through drug and siRNA screens, showing ROCK2 inhibitors could treat cystic kidney disease.

bioRxiv · Nov 26, 2020Cell Biology